An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 25, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Migraine
Trial Locations (11)

13100

RECRUITING

ZIV Medical Center /ID# 257360, Safed

91031

RECRUITING

Shaare Zedek Medical Center /ID# 254169, Jerusalem

91120

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 257352, Jerusalem

4420123

RECRUITING

Maccabi Healthcare Services /ID# 254171, Kfar Saba

4428164

RECRUITING

Meir Medical Center /ID# 254170, Kfar Saba

5265601

RECRUITING

The Chaim Sheba Medical Center /ID# 254550, Ramat Gan

5591236

RECRUITING

Clalit HMO /ID# 257364, Gani Tikva

5822012

RECRUITING

Edith Wolfson Medical Center /ID# 269740, Holon

6423906

RECRUITING

Tel Aviv Sourasky Medical Center /ID# 263089, Tel Aviv

7747629

RECRUITING

Assuta Ashdod Medical Center /ID# 260020, Ashdod

8410101

COMPLETED

Soroka University Medical Center /ID# 254551, Beersheba

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY